All transplant centers participating in the CIBMTR must submit a Pre-TED (2400) Form for each allogeneic (related or unrelated) hematopoietic cell transplant (HCT). The Pre-TED is a requirement of the SCTOD for all United States transplant centers when either the stem cell donation or the transplant occurs within the United States. For more information regarding the SCTOD, see General Instructions, Stem Cell Therapeutics Outcomes Database.
Although data regarding recipients receiving autologous HCT are not required to be submitted as part of the C.W. Bill Young Transplant Program, the CIBMTR is highly committed to collecting data on these recipients for research studies. Centers choosing to report autologous data to the CIBMTR must report on all autologous transplants performed at their center. For more information regarding data reporting for autologous HCT, see HCT
The Pre-TED may be submitted to the CIBMTR up to two weeks prior to the start of the recipient’s preparative regimen (see Helpful Hint below).
For recipients receiving a subsequent HCT:
Transplant centers must submit a Pre-TED for all subsequent HCTs; this includes recipients assigned to the TED Forms and the Comprehensive Report Forms by the form selection algorithm.
For the majority of subsequent HCTs, the recipient will remain on the original follow-up form track assigned by the form selection algorithm. For more information regarding center type and the form selection algorithm, see Section 1 in the Center Reference Guide. A recipient may need to change tracks if enrolled on a study that requires comprehensive forms.
For recipients of multiple transplants, transplant centers are not granted access to the new Pre-TED Form in FormsNet3 until the Post-TED (Form 2450) or Post-Infusion Data Form (Form 2100) from the previous transplant has been completed.
Transplant centers can use the FormsNet3 application to determine if a Pre-TED is due by either: 1) accessing the Forms Due Report, or 2) entering the recipient’s unique ID (CRID) in the Patient Forms Due field.
Q1-23: Recipient Information
Q24-43: Hematopoietic Cellular Transplant (HCT) and Cellular Therapy
Q44-82: Donor Information
Q83-86: Clinical Status of Recipient Prior to the Preparative Regimen
Q87-120: Comorbid Conditions
Q121-135: Pre-HCT Preparative Regimen
Q136-144: Additional Drugs Given in the Peri-Transplant Period
Q145-147: GVHD Prophylaxis
Q146-150: Post-HCT Disease Therapy Planned as of Day 0
Q151: Prior Exposure: Potential Study Eligibility
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.
|10/29/2021||2400: Pre-TED||Modify||Version 8 of the 2400: Pre-TED section of the Forms Instruction Manual released. Version 8 corresponds to revision 9 of the Form 2400.|
Need more help with this?
Don’t hesitate to contact us here.